Search research articles
Contact Us
Filters
Showing results (11-20 of 62) with videos related to
Page
of 7
Sort By:
British Journal of Haematology
|
June 27, 2007
Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53
Orly Weizer-Stern, Konstantin Adamsky, Ofer Margalit, et al.
Cancer Reports (Hoboken, N.J.)
|
June 2, 2022
Serological response to a third booster dose of BNT162b2 COVID-19 vaccine among seronegative cancer patients
Einat Shacham Shmueli, Yaacov R Lawrence, Galia Rahav, et al.
JCO Oncology Practice
|
January 13, 2021
Mortality Among Neutropenic Cancer Patients Within the United States: The Association With Hospital Volume
Damien Urban, Gavin E Urban, Ofer Margalit, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 9, 2017
Short- and Long-Term Survival in Metastatic Pancreatic Adenocarcinoma, 1993-2013
Talia Golan, Tal Sella, Ofer Margalit, et al.
Neoplasia (New York, N.Y.)
|
August 21, 2012
Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer
Hiroshi Katoh, Keishi Yamashita, Mina Waraya, et al.
Journal of Traumatic Stress
|
December 7, 2018
Posttraumatic Stress Disorder and Cancer Risk: A Nested Case-Control Study
Elana Cohn, Ido Lurie, Yu-Xiao Yang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2024
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
Ofer Margalit, Amos Stemmer, William J Chapin, et al.
Investigational New Drugs
|
August 3, 2014
CG100649, a novel COX-2 inhibitor, inhibits colorectal adenoma and carcinoma growth in mouse models
Sun-Hee Kim, Ofer Margalit, Hiroshi Katoh, et al.
Clinical Colorectal Cancer
|
February 20, 2021
Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
Shun Yu, Ronac Mamtani, Mark H O'Hara, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 27, 2018
A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer
Ofer Margalit, Ronac Mamtani, Yu-Xiao Yang, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 62) with videos related to
Sort By:
Page
of 7
British Journal of Haematology
|
June 27, 2007
Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53
Orly Weizer-Stern, Konstantin Adamsky, Ofer Margalit, et al.
Cancer Reports (Hoboken, N.J.)
|
June 2, 2022
Serological response to a third booster dose of BNT162b2 COVID-19 vaccine among seronegative cancer patients
Einat Shacham Shmueli, Yaacov R Lawrence, Galia Rahav, et al.
JCO Oncology Practice
|
January 13, 2021
Mortality Among Neutropenic Cancer Patients Within the United States: The Association With Hospital Volume
Damien Urban, Gavin E Urban, Ofer Margalit, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 9, 2017
Short- and Long-Term Survival in Metastatic Pancreatic Adenocarcinoma, 1993-2013
Talia Golan, Tal Sella, Ofer Margalit, et al.
Neoplasia (New York, N.Y.)
|
August 21, 2012
Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer
Hiroshi Katoh, Keishi Yamashita, Mina Waraya, et al.
Journal of Traumatic Stress
|
December 7, 2018
Posttraumatic Stress Disorder and Cancer Risk: A Nested Case-Control Study
Elana Cohn, Ido Lurie, Yu-Xiao Yang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2024
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
Ofer Margalit, Amos Stemmer, William J Chapin, et al.
Investigational New Drugs
|
August 3, 2014
CG100649, a novel COX-2 inhibitor, inhibits colorectal adenoma and carcinoma growth in mouse models
Sun-Hee Kim, Ofer Margalit, Hiroshi Katoh, et al.
Clinical Colorectal Cancer
|
February 20, 2021
Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
Shun Yu, Ronac Mamtani, Mark H O'Hara, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 27, 2018
A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer
Ofer Margalit, Ronac Mamtani, Yu-Xiao Yang, et al.
Page
of 7